Seed VC · UK
A venture capital firm for visionary innovators focused on building innovative life sciences businesses by turning breakthrough science into approved medicines or medical products, starting and investing in early and mid-stage companies with a first-in-class or best-in-class approach.
Business models
biotech_therapeutics, deeptech_ip, platform
Customer segments
Researchers, Enterprise
Geography
UK, Europe, US
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Advent Life Sciences writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Advent Life Sciences alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Advent Life Sciences is one of them — and we'll tell you exactly where they sit in your top 100.